Atlas Trials

First in Human Study of YB1-X7 Injection

Clinical trial NCT06889675 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06889675
Sponsor
Shanghai Salvectors Biotechnology LTD.
Status
NOT_YET_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Advanced Solid Tumors
Start date
2025-03-15
Primary completion
2027-01-31
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.